10 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Symphony™ Thrombectomy System; Symphony™ 16F 82cm Thrombectomy System

FDA 510(k)
FDA Class 2 ·Cardiovascular

Darby Dental Supply, LLC

FDA UDI
DARBY DENTAL SUPPLY, LLC·00889813034224·Hedstrom Files with Silicone Stops 31mm #45

Philips

FDA UDI
Sbo Hearing A/S·05714464093854·HEARLINK 1500 MNR TP

RESSCAN

FDA 510(k)
FDA Class 2 ·Anesthesiology

LOOP LED Curing Light System

FDA 510(k)
FDA Class 2 ·Dental

GOODTECH

FDA Adverse Event
Malfunction ·B. BRAUN MEDICAL INC.·Product code DYG·December 1, 2008

*

FDA Adverse Event
Malfunction ·KINETIC CONCEPTS, INC.·Product code OMP·August 28, 2011

HARMONIC ACE+

FDA Adverse Event
Malfunction ·ETHICON ENDO-SURGERY, INC.·Product code LFL·July 25, 2013

Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.

FDA Enforcement
Class II ·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models F102, F110, F111. Sterilized using ethylene oxide. Boston Scientific, 4100 Hamline Avenue North, St. Paul, MN 55112-5798 USA. Indicated for patients who are at risk for sudden cardiac death due to ventricular arrhythmias and may require pacing support.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 23, 2013